{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:09:02Z","timestamp":1778540942136,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.neuropharm.2004.04.003","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T17:06:22Z","timestamp":1087491982000},"page":"263-272","source":"Crossref","is-referenced-by-count":54,"title":["Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia"],"prefix":"10.1016","volume":"47","author":[{"given":"V.C.","family":"Ab\u00edlio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Grassl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"Calzavara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Registro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"D\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.de A.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Frussa-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.04.003_BIB1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0278-5846(02)00340-8","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione\/reduced glutathione ratio (GSSG\/GSH) enhancement in rats","volume":"27","author":"Ab\u00edlio","year":"2003","journal-title":"Progress in Neuro-psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00213-002-1081-7","article-title":"Effects of melatonin on orofacial movements in rats","volume":"161","author":"Ab\u00edlio","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj2630273","article-title":"Brain chemiluminescence and oxidative stress in hyperthyroid rats","volume":"263","author":"Adamo","year":"1989","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesia in rats","volume":"61","author":"Andreassen","year":"2000","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(95)11756-M","article-title":"Altered expression of dopamine D2 m RNA splice variants in brain and pituitary of spontaneously hypertensive rat","volume":"195","author":"Autelitano","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.65020919.x","article-title":"3-Nitropropionic acid neurotoxicity is attenuated in copper\/zinc superoxide dismutase transgenic mice","volume":"65","author":"Beal","year":"1995","journal-title":"Journal of Neurochemestry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0006-2952(89)90198-6","article-title":"Monoamine oxidase brain aging and neurodegenerative diseases","volume":"38","author":"Benedetti","year":"1989","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB8","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","first-page":"3","article-title":"Pharmacokinetics: the dynamics of drug absorption distribution and elimination","author":"Benet","year":"1996"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0197-4580(97)00152-8","article-title":"Effects of age on a new animal model of tardive dyskinesia","volume":"18","author":"Bergamo","year":"1997","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Motochondrial free radical generation oxidative stress and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(01)00255-X","article-title":"The motochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats","volume":"26","author":"Calvente","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB12","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"1497","article-title":"Tardive dyskinesia\u2014pathophysiology","author":"Casey","year":"1995"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.149.6.773","article-title":"Treatment of tardive dyskinesia with vitamin E","volume":"149","author":"Egan","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1176\/ajp.147.4.505","article-title":"Vitamin E in the treatment of tardive dyskinesia","volume":"147","author":"Elkashef","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB15","first-page":"354","article-title":"Altered behavioral response to a D2 agonist LY141865 in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats","volume":"227","author":"Fuller","year":"1983","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020070089","article-title":"Haloperidol-induced neurotoxicity\u2014possible implications for tardive dyskinesia","volume":"107","author":"Galili-Mosberg","year":"2000","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB17","series-title":"Dyskinesia: Research and Treatment","first-page":"99","article-title":"Pathophysiological mechanisms underlying tardive dyskinesia","author":"Gerlach","year":"1985"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1471-4159.1995.64031216.x","article-title":"Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type","volume":"64","author":"Gsell","year":"1995","journal-title":"Journal of Neurochemestry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-4522(93)90188-L","article-title":"Up-regulation of dopamine receptors in the brain of spontaneously hypertensive rats: an autoradiographic analysis","volume":"52","author":"Kirouac","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0192-0561(99)00036-3","article-title":"Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: a possible mechanism for its antitumoral effects","volume":"21","author":"Kleeb","year":"1999","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0924-9338(02)00647-8","article-title":"Tardive dyskinesia and antipsychotics: a review","volume":"17","author":"Llorca","year":"2002","journal-title":"European Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen free radicals and neuropsychiatric illness","volume":"48","author":"Lohr","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130050039","article-title":"Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods","volume":"148","author":"Lohr","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","article-title":"Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia","volume":"28","author":"Lohr","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"Journal of Biological Chemestry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","article-title":"Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer\u2019s disease","volume":"150","author":"Marcus","year":"1998","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0704717","article-title":"Carvedilol attenuates neurolpetic-induced orofacial dyskinesia: possible antioxidant mechanisms","volume":"136","author":"Naidu","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB29","first-page":"850","article-title":"Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats","volume":"257","author":"Neisewander","year":"1991","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02244874","article-title":"Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia","volume":"116","author":"Neisewander","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(96)00155-0","article-title":"Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia","volume":"305","author":"Neisewander","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB32","series-title":"Dopaminergic System: Its Evolution from Biology to Clinical Aspects","first-page":"61","article-title":"Behavioural models of tardive dyskinesia in rodents: a chronological review","author":"Palermo-Neto","year":"2001"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(98)00546-9","article-title":"Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats","volume":"356","author":"Queiroz","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0301-0082(98)00052-5","article-title":"Oxidative damage in the central nervous system: protection by melatonin","volume":"56","author":"Reiter","year":"1998","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.1994.tb56824.x","article-title":"Cellular and molecular mechanisms of impaired dopaminergic function during aging","volume":"719","author":"Roth","year":"1994","journal-title":"Annals of the New York Academy of Science"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(95)00135-D","article-title":"Altered dopaminergic function in the prefrontal cortex nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder\u2014the spontaneously hypertensive rat","volume":"676","author":"Russell","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1471-4159.1998.71031002.x","article-title":"Induction of reactive oxygen species in neurons by haloperidol","volume":"71","author":"Sagara","year":"1998","journal-title":"Journal of Neurochemestry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB38","series-title":"Neuroleptic-induced movement disorders","first-page":"13","article-title":"Aging and tardive dyskinesia","author":"Saltz","year":"1997"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(76)90119-9","article-title":"Differential attenuation of some effects of haloperidol in rats given scopolamine","volume":"39","author":"Setler","year":"1976","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB40","first-page":"34","article-title":"Ein eigentumiliches syndrom in eralen Bereich bei","volume":"28","author":"Shonecker","year":"1957","journal-title":"Megaphen Applikation Nervenartz"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-5793(79)81346-0","article-title":"Increased bilary glutathione disulfide release in chronically ethanol-treated rats","volume":"103","author":"Sies","year":"1979","journal-title":"FEBS Letters"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neuroscience Biobehavior Reviews"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(80)90240-2","article-title":"Differential effects of ageing on distincts features of apomorphine stereotypy in the adult rat","volume":"20","author":"Waddington","year":"1980","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB46","series-title":"CNS receptors\u2014from molecular pharmacology to behavior","first-page":"299","article-title":"Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments","author":"Waddington","year":"1983"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00430756","article-title":"Age difference in apomorphine-induced stereotypy in rats: relationship to plasma and brain concentration","volume":"76","author":"Watanabe","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB48","first-page":"470","article-title":"Brain dopamine transporter in spontaneously hypertensive rats","volume":"38","author":"Watanabe","year":"1997","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0278-5846(89)90036-5","article-title":"Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?","volume":"13","author":"Wolfarth","year":"1989","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2004.04.003_BIB50","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1023\/A:1014237215200","article-title":"Presynaptic modulation of K+-evoked [3H] dopamine release in striatal and frontal cortical synaptosomes of normotensive and spontaneous hypertensive rats","volume":"26","author":"Yousfi-Alaoui","year":"2001","journal-title":"Neurochemistry Research"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080400108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080400108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T12:18:17Z","timestamp":1624450697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839080400108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S002839080400108X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.04.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}